-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $145

Benzinga·12/11/2025 18:45:12
Listen to the news
Needham analyst Joseph Stringer maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target from $120 to $145.